Based on these findings, we propose that Meflin is a specific marker of tumor-restraining CAFs (rCAFs), the existence of which has been postulated previously (Lee et al, 2014; Rhim et al, 2014; Shin et al, 2014; Özdemir et al, 2014). This evidence concerns the gene ISLR and neoplasm.